Prospera Financial Services’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,128
| Closed | -$188K | – | 1131 |
|
|
2024
Q2 | $188K | Sell |
12,128
-3,945
| -25% | -$61.1K | 0.01% | 1077 |
|
|
2024
Q1 | $256K | Sell |
16,073
-2,419
| -13% | -$38.6K | 0.01% | 957 |
|
|
2023
Q4 | $311K | Buy |
18,492
+1,351
| +8% | +$22.7K | 0.01% | 833 |
|
|
2023
Q3 | $200K | Hold |
17,141
| – | – | 0.01% | 950 |
|
|
2023
Q2 | $230K | Sell |
17,141
-311
| -2% | -$4.18K | 0.01% | 905 |
|
|
2023
Q1 | $289K | Buy |
17,452
+631
| +4% | +$10.5K | 0.01% | 797 |
|
|
2022
Q4 | $313K | Sell |
16,821
-9,791
| -37% | -$182K | 0.02% | 684 |
|
|
2022
Q3 | $341K | Sell |
26,612
-1,932
| -7% | -$24.8K | 0.02% | 618 |
|
|
2022
Q2 | $200K | Sell |
28,544
-2,260
| -7% | -$15.8K | 0.01% | 737 |
|
|
2022
Q1 | $255K | Sell |
30,804
-4,586
| -13% | -$38K | 0.01% | 793 |
|
|
2021
Q4 | $240K | Buy |
+35,390
| New | +$240K | 0.01% | 775 |
|